| (TWD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 113.42M | — |
| Operating expense | — | — |
| Net income | -141.25M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 1762.TW returned +30.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +47.8% |
| 1 year | +30.2% |
| 5 years | -52.0% |
| 10 years | +44.7% |
| All-time high | $95.60 (Apr 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in 1762.TW would be worth today ›No. Chunghwa Chemical Synthesis & Biotech Co., Ltd. has not paid a dividend in the past 12 months.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. is part of the Healthcare sector.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. has a market cap of 2.75B TWD, based on the latest quote.
